Prognostic Value of Pre- and Post-Treatment PET-CT Metrics After Definitive Chemoradiation for Anal Canal Cancer
Purpose Although post-treatment FDG-PET/CT is frequently obtained following definitive chemoradiation (CRT) for locally advanced anal canal cancer (LAACC), its prognostic utility remains uncertain. We hypothesized that quantitative PET/CT metrics would be associated with overall survival (OS) and that pre-treatment metabolic parameters would provide greater prognostic information than post-treatment metabolic response. Methods We conducted a retrospective cohort study of patients with LAACC who underwent definitive CRT and both pre-treatment and post-treatment fluorodeoxyglucose (FDG) PET/CT. Quantitative PET metrics were extracted, including mean SUL, total lesion glycolysis (TLG), metabolic tumor volume (MTV), maximum SUL, and peak SUL. OS was estimated using the Kaplan-Meier method. Associations between PET-derived variables and OS were evaluated using univariable Cox proportional hazards regression, with optimal cutoffs identified using maximally selected rank statistics (MaxStat). Results Forty-five patients were included (median age 57.7 years), with post-treatment PET/CT performed at a median of 4.4 months following CRT. Lean body mass (HR 3.10, 95% CI 1.01–9.50; p = 0.049) and pre-treatment primary tumor mean SUL (HR 4.93, 95% CI 1.40–17.37; p = 0.013), size (HR 4.01, 95% CI 1.22–13.17; p = 0.022), TLG (HR 3.68, 95% CI 1.11–12.14; p = 0.033), and peak SUL (HR 3.31, 95% CI 1.02–10.72; p = 0.046) were associated with OS in exploratory univariable analyses. Post-treatment, higher weight (HR 4.94, 95% CI 1.06–22.96; p=0.041; cutoff 60.42 kg; N=45) and lean body mass (HR 4.82, 95% CI 1.06–21.90; p=0.042; cutoff 44.50 kg; N=44) were associated with worse OS. No post-treatment PET-derived metabolic parameters met the nominal threshold for statistical significance. Among patients with higher baseline metabolic activity, greater reduction in mean SUL following CRT demonstrated a nonsignificant trend toward improved OS. Conclusion Pre-treatment FDG-PET/CT metabolic parameters demonstrated stronger associations with OS than post-treatment metabolic parameters in this exploratory cohort. Baseline tumor metabolic activity may provide useful prognostic information in patients with LAACC, warranting validation in larger prospective studies.
Authors
- Ifeanyichukwu Chinedu Ogobuiro (ORCID: https://orcid.org/0000-0002-1094-6727)
- Aaron Howard Wolfson (ORCID: https://orcid.org/0000-0003-0918-8970)
- Aren Singh Saini (ORCID: https://orcid.org/0000-0002-6163-3288)
- Kyle R. Padgett (ORCID: https://orcid.org/0000-0002-6277-5317)
- Russ A. Kuker (ORCID: https://orcid.org/0000-0002-0074-6596)
- Justin T. Dreyer
- Yunze Yang (ORCID: https://orcid.org/0000-0003-4776-4588)
- Armando Vera
- Raksha M. Narasimhan (ORCID: https://orcid.org/0009-0009-2380-5681)
- Yuntao Wang (ORCID: https://orcid.org/0009-0005-5499-6258)
Institutions
- University of Miami (US)
- Sylvester Comprehensive Cancer Center (US)
Publication Details
- Journal
- Journal of Gastrointestinal Cancer
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1007/s12029-026-01640-6
- Primary Topic
- Colorectal and Anal Carcinomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00